Tower Research Capital (TRC)’s Panacea Acquisition Corp. II Class A Ordinary Shares PANA Stock Holding History

Tower Research Capital (TRC)’s Portfolio PANA Stock Details PANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-331	Closed	-$3K	–	6614
2022 Q4	$3K	Sell	331 -2	-0.6%	-$20	﹤0.01%	5298
2022 Q3	$3K	Sell	333 -7	-2%	-$68	﹤0.01%	5480
2022 Q2	$3K	Sell	340 -6	-2%	-$59	﹤0.01%	5465
2022 Q1	$3K	Buy	+346	New	+$3.35K	﹤0.01%	5471

Other funds holding PANA

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCP

RIT Capital Partners London, United Kingdom $621M AUM 14.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Tower Research Capital (TRC)'s PANA Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) in Q1 2023, closing a stake of 331 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in PANA in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q4 2022. 54 funds tracked by Wall St. Rank hold PANA as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Panacea Acquisition Corp. II Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 331 Panacea Acquisition Corp. II Class A Ordinary Shares shares in Q1 2023, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares in Q1 2022 and held it in 4 quarters.
Tower Research Capital (TRC)'s Panacea Acquisition Corp. II Class A Ordinary Shares position peaked at $3K in Q4 2022.
54 funds tracked by Wall St. Rank held Panacea Acquisition Corp. II Class A Ordinary Shares as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.